<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02412826</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00038455</org_study_id>
    <nct_id>NCT02412826</nct_id>
  </id_info>
  <brief_title>Abstats: Computer-aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Acute Pancreatitis</brief_title>
  <official_title>Abstats: Computer-aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct a pilot test of an abdominal acoustic sensor on
      patients with acute pancreatitis to determine the correlation of acoustic signals with
      symptoms reported by the patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will use the AbStats device, that measure IAAS (intraabdominal acoustic signals)
      and intestinal rate and will correlate this data with symptoms reported by patients
      hospitalized for acute pancreatitis.

      The AbStats multi-sensor wireless abdominal monitoring system includes low profile acoustic
      sensors that are applied to the anterior abdominal wall with Tegaderm and monitors sounds
      emanating from the GI tract. The acoustic sensors continuously and non-invasively monitor and
      capture audio signals representing GI and abdominal wall function. The captured data is
      recorded in a synchronized manner from all sensors.

      We will place the AbStats sensor on all patients immediately after admission to the hospital.
      Only study staff trained on the AbStats system will apply the sensors, which fit externally
      around the abdomen. A physician member of our study staff will be available at all times to
      help position the device if needed. We will continuously record AbStats acoustic signals for
      the duration of the hospitalization, with the option to discontinue as clinically required or
      requested by the provider or patient. A research coordinator will collect clinical data from
      medical records and enter the data into a secure spreadsheet on CSMC servers. Patients will
      be asked to keep a daily diary of symptoms. In this diary, the patients will be asked to
      record information about their food consumption (if any), bowel movements (if any and if
      associated with contrast from CT imaging or with the use of suppositories/ laxative),
      specific symptoms, and whether the sensor was removed for any period of time during the day.
      This will allow us to compare the data collected by the AbStats sensor with self-reported
      symptoms noted by patients. Physicians and nurses will not be made aware of the AbStats
      readings so as to eliminate the Hawthorne effect. Patients will be managed according to
      standard-of-care practice and the data collected by the AbStats device will not be
      incorporated into clinical care.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Re-hospitalization for acute pancreatitis</measure>
    <time_frame>30 days</time_frame>
    <description>Patients who are re-admitted to the hospital for acute pancreatitis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability to PO after discharge</measure>
    <time_frame>30 days</time_frame>
    <description>Patients who are able to tolerate oral itnake after discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms</measure>
    <time_frame>30 days</time_frame>
    <description>GI symptoms after discharge</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Acute pancreatitis</arm_group_label>
    <description>Patients presenting to the hospital with acute pancreatitis that will receive AbStats sensor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abstats sensor</intervention_name>
    <description>The AbStats abdominal biosensor will be applied to the abdomen of patients who are admitted with acute pancreatitis.</description>
    <arm_group_label>Acute pancreatitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be patients who present to Cedars-Sinai Medical Center with the
        diagnosis of acute pancreatitis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  diagnosis of acute pancreatitis; must meet at least 2 out of the 3 following critiera:

               1. abdominal pain consistent with acute pancreatitis

               2. serum amylase/lipase &gt;3 times upper limit of normal

               3. characteristic findings from abdominal imaging

          -  able to provide informed consent

        Exclusion Criteria:

          -  unable to provide consent

          -  transfer patients

          -  cognitive inability to follow directions to maintain sensors in place

          -  unable to place abdominal sensors on patients

          -  abdominal cellulitis

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elham Afghani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Negro P, D'Amore L, Saputelli A, Talarico C, Scaccia M, Tuscano D, Gossetti F, Carboni M. Colonic lesions in pancreatitis. Ann Ital Chir. 1995 Mar-Apr;66(2):223-31. Review.</citation>
    <PMID>7668499</PMID>
  </reference>
  <reference>
    <citation>Abcarian H, Eftaiha M, Kraft AR, Nyhus LM. Colonic complications of acute pancreatitis. Arch Surg. 1979 Sep;114(9):995-1001.</citation>
    <PMID>485850</PMID>
  </reference>
  <reference>
    <citation>Russell JC, Welch JP, Clark DG. Colonic complications of acute pancreatitis and pancreatic abscess. Am J Surg. 1983 Nov;146(5):558-64.</citation>
    <PMID>6638261</PMID>
  </reference>
  <reference>
    <citation>Shi LL, Liu MD, Chen M, Zou XP. Involvement of interstitial cells of Cajal in experimental severe acute pancreatitis in rats. World J Gastroenterol. 2013;19(14):2179-86. doi: 10.3748/wjg.v19.i14.2179.</citation>
    <PMID>23599644</PMID>
  </reference>
  <reference>
    <citation>Leveau P, Wang X, Soltesz V, Ihse I, Andersson R. Alterations in intestinal motility and microflora in experimental acute pancreatitis. Int J Pancreatol. 1996 Oct;20(2):119-25.</citation>
    <PMID>8968867</PMID>
  </reference>
  <reference>
    <citation>Seerden TC, De Man JG, Holzer P, Van den Bossche RM, Herman AG, Pelckmans PA, De Winter BY. Experimental pancreatitis disturbs gastrointestinal and colonic motility in mice: effect of the prokinetic agent tegaserod. Neurogastroenterol Motil. 2007 Oct;19(10):856-64.</citation>
    <PMID>17883437</PMID>
  </reference>
  <reference>
    <citation>Wang X, Gong Z, Wu K, Wang B, Yuang Y. Gastrointestinal dysmotility in patients with acute pancreatitis. J Gastroenterol Hepatol. 2003 Jan;18(1):57-62.</citation>
    <PMID>12519225</PMID>
  </reference>
  <reference>
    <citation>Davis S, Parbhoo SP, Gibson MJ. The plain abdominal radiograph in acute pancreatitis. Clin Radiol. 1980 Jan;31(1):87-93.</citation>
    <PMID>7357829</PMID>
  </reference>
  <reference>
    <citation>Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ. Postoperative ileus: it costs more than you expect. J Am Coll Surg. 2010 Feb;210(2):228-31. doi: 10.1016/j.jamcollsurg.2009.09.028. Epub 2009 Nov 18.</citation>
    <PMID>20113944</PMID>
  </reference>
  <reference>
    <citation>Tenner S, Baillie J, DeWitt J, Vege SS; American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416. doi: 10.1038/ajg.2013.218. Epub 2013 Jul 30. Erratum in: Am J Gastroenterol. 2014 Feb;109(2):302.</citation>
    <PMID>23896955</PMID>
  </reference>
  <reference>
    <citation>Yadav D, Lee E, Papachristou GI, O'Connell M. A population-based evaluation of readmissions after first hospitalization for acute pancreatitis. Pancreas. 2014 May;43(4):630-7. doi: 10.1097/MPA.0000000000000078.</citation>
    <PMID>24681876</PMID>
  </reference>
  <reference>
    <citation>Vipperla K, Papachristou GI, Easler J, Muddana V, Slivka A, Whitcomb DC, Yadav D. Risk of and factors associated with readmission after a sentinel attack of acute pancreatitis. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1911-9. doi: 10.1016/j.cgh.2014.04.035. Epub 2014 May 9.</citation>
    <PMID>24815327</PMID>
  </reference>
  <reference>
    <citation>Tomomasa T, Morikawa A, Sandler RH, Mansy HA, Koneko H, Masahiko T, Hyman PE, Itoh Z. Gastrointestinal sounds and migrating motor complex in fasted humans. Am J Gastroenterol. 1999 Feb;94(2):374-81.</citation>
    <PMID>10022632</PMID>
  </reference>
  <reference>
    <citation>Augustyniak P. Wearable wireless heart rate monitor for continuous long-term variability studies. J Electrocardiol. 2011 Mar-Apr;44(2):195-200. doi: 10.1016/j.jelectrocard.2010.11.014.</citation>
    <PMID>21353066</PMID>
  </reference>
  <reference>
    <citation>Shambroom JR, FÃ¡bregas SE, Johnstone J. Validation of an automated wireless system to monitor sleep in healthy adults. J Sleep Res. 2012 Apr;21(2):221-30. doi: 10.1111/j.1365-2869.2011.00944.x. Epub 2011 Aug 22.</citation>
    <PMID>21859438</PMID>
  </reference>
  <reference>
    <citation>Spiegel BM, Kaneshiro M, Russell MM, Lin A, Patel A, Tashjian VC, Zegarski V, Singh D, Cohen SE, Reid MW, Whitman CB, Talley J, Martinez BM, Kaiser W. Validation of an acoustic gastrointestinal surveillance biosensor for postoperative ileus. J Gastrointest Surg. 2014 Oct;18(10):1795-803. doi: 10.1007/s11605-014-2597-y. Epub 2014 Aug 5.</citation>
    <PMID>25091837</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2015</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Elham Afghani</investigator_full_name>
    <investigator_title>Assistant Director, Clinical Pancreatology</investigator_title>
  </responsible_party>
  <keyword>pancreatitis</keyword>
  <keyword>acoustic</keyword>
  <keyword>sensor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

